CapyFin

Calendar Reports

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Royalty Pharma - CapyFin

Royalty Pharma

RPRX · NASDAQ🇺🇸

Earnings Dividends Seasonality Metrics

Reports earnings in 4 days

before market opens

Previous year: $565M

Previous year: $1.04

Royalty Receipts Growth

Royalty Receipts

Previous year: $732M

Portfolio Receipts Growth

Cash and Equivalents

Previous year: $950M

Loading...

Key Statistics

Market Cap

$17.8B

P/E Ratio

16.56

Sector

N/A

Industry

N/A

52-Week High

$44.5

52-Week Low

$30.8

Royalty Receipts Growth

11%

Royalty Receipts

$811M

Portfolio Receipts Growth

11%

Portfolio Receipts

$814M

Capital Deployment

$1B

Royalty Pharma

Unlock previous datapoints

Royalty Pharma

Unlock previous datapoints

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Royalty Pharma Dividend Per Share

Track dividend payments, yield trends, and growth metrics over time

Royalty Pharma

Dividend Stats

Dividend Yield2.15%

FrequencyQuarterly

Dividend Growth

1Y

-73.81%

3Y

-71.05%

5Y

-26.67%

10Y

—

Yield Growth

1Y

+15.62%

3Y

+92.97%

5Y

—

10Y

—